trending Market Intelligence /marketintelligence/en/news-insights/trending/swddoccztfadr0r7gfjo0a2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Xenon Pharmaceuticals raises $29.2M under equity offering program

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Xenon Pharmaceuticals raises $29.2M under equity offering program

Xenon Pharmaceuticals Inc. said it raised about $29.2 million as of July 3 under an equity offering program.

The proceeds are from the sale of 3,440,000 common shares, the Burnaby, British Columbia-based biopharmaceutical company said.

In May, Xenon entered a sales agreement with Stifel Nicolaus & Co. Inc. for the sale of up to $30 million of common shares.